Skip to content

Peer delivered support intervention for people who hear voices: Pilot randomised controlled trial

Effect of a peer delivered support intervention for people who hear voices on subjective impact of voices

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000974808
Enrollment
35
Registered
2012-09-10
Start date
2012-11-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Hearing voices (auditory verbal hallucination) is a potentially distressing and disabling experience which often persists in spite of treatment with medication. This pilot study examines whether it is helpful for people who hear voices to receive assistance in coping with this experience from someone else who hears voices and has adapted to living with this experience.

Interventions

Participants will receive 12 weekly one hour one-to-one sessions of a support intervention for hearing voices (auditory verbal hallucinations) from a peer mental health worker who has had personal lived experience of hearing voices themselves. The intervention will involve buidling a shared understanding of the participant's experience of hearing voices and using this to inform how to respond to hearing voices and cope with this experience more effectively. The intervention group will receive t

Participants will receive 12 weekly one hour one-to-one sessions of a support intervention for hearing voices (auditory verbal hallucinations) from a peer mental health worker who has had personal lived experience of hearing voices themselves. The intervention will involve buidling a shared understanding of the participant's experience of hearing voices and using this to inform how to respond to hearing voices and cope with this experience more effectively. The intervention group will receive the intervention alongside treatment as usual (TAU) in the 3 month period immediately following randomisation, whilst the control group will receive the intervention after a 3 month TAU wait list period.

Sponsors

Monash Alfred Psychiatry Research Centre
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Auditory verbal hallucinations at least weekly over the past six months associated with significant distress or disability

Exclusion criteria

Recent (past 8 weeks) or planned change in antipsychotic medication Currently receiving individual psychological therapy Insufficient English or intellectual functioning to meaningfully participate

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026